Citius Pharmaceuticals Inc (CTXR)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

11 COMMERCE DRIVE CRANFORD, NJ 07016

Citius is a late-stage specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives and cancer care.

Data as of 2021-09-26 20:57:52 -0400
Market Cap305.097 Million Shares Outstanding145.979 Million Avg 30-day Volume3.168 Million
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.59 52-week High/Low4.56 / 0.8729 Next Earnings Date2021-12-16 Price to Cash FLow (P/CF) -81.0027
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from CTXR instead.

View recent insider trading info

Funds Holding CTXR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CTXR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HOLUBIAK MYRON Z PRESIDENT AND CEO

  • Officer
  • Director
  • 10% Owner
4,366,271 2021-07-22 2

SAFIR HOWARD

  • Director
150,405 2021-07-22 3

MAZUR LEONARD L EXECUTIVE CHAIRMAN

  • Officer
  • Director
  • 10% Owner
19,033,803 2021-07-22 2

DUTIA SUREN G

  • Director
151,667 2021-07-22 3

WEBB CAROL

  • Director
150,405 2021-07-22 3

KANE WILLIAM

  • Director
150,405 2021-07-22 3

HOLUKA EUGENE MYRON

  • Director
140,749 2021-07-22 3

BARTUSHAK JAIME CHIEF FINANCIAL OFFICER

  • Officer
528,620 2021-07-22 2

CZUCZMAN MYRON CHIEF MEDICAL OFFICER

  • Officer
0 2020-07-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CITIUS PHARMACEUTICALS INC CTXR 2021-09-27 22:15:03 UTC -2.6875 2.7575 950000
CITIUS PHARMACEUTICALS INC CTXR 2021-09-27 21:45:03 UTC -2.6864 2.7564 950000
CITIUS PHARMACEUTICALS INC CTXR 2021-09-27 21:15:03 UTC -2.6864 2.7564 950000
CITIUS PHARMACEUTICALS INC CTXR 2021-09-27 20:45:04 UTC -2.0054 2.0754 950000
CITIUS PHARMACEUTICALS INC CTXR 2021-09-27 20:15:03 UTC -2.0054 2.0754 950000
CITIUS PHARMACEUTICALS INC CTXR 2021-09-27 19:45:03 UTC -2.0054 2.0754 950000
CITIUS PHARMACEUTICALS INC CTXR 2021-09-27 19:15:03 UTC -2.0054 2.0754 950000
CITIUS PHARMACEUTICALS INC CTXR 2021-09-27 18:45:02 UTC -2.0054 2.0754 950000
CITIUS PHARMACEUTICALS INC CTXR 2021-09-27 18:15:03 UTC -2.0054 2.0754 950000
CITIUS PHARMACEUTICALS INC CTXR 2021-09-27 17:45:03 UTC -2.0054 2.0754 750000
CITIUS PHARMACEUTICALS INC CTXR 2021-09-27 17:15:04 UTC -2.0054 2.0754 750000
CITIUS PHARMACEUTICALS INC CTXR 2021-09-27 16:45:03 UTC -2.2272 2.2972 750000
CITIUS PHARMACEUTICALS INC CTXR 2021-09-27 16:15:03 UTC -2.2272 2.2972 750000
CITIUS PHARMACEUTICALS INC CTXR 2021-09-27 15:45:03 UTC -2.2272 2.2972 750000
CITIUS PHARMACEUTICALS INC CTXR 2021-09-27 15:15:03 UTC -2.2272 2.2972 700000
CITIUS PHARMACEUTICALS INC CTXR 2021-09-27 14:45:02 UTC -2.2124 2.2824 700000
CITIUS PHARMACEUTICALS INC CTXR 2021-09-27 14:15:03 UTC -2.2124 2.2824 800000
CITIUS PHARMACEUTICALS INC CTXR 2021-09-27 13:45:03 UTC -2.2124 2.2824 800000
CITIUS PHARMACEUTICALS INC CTXR 2021-09-27 13:15:03 UTC -2.2124 2.2824 800000
CITIUS PHARMACEUTICALS INC CTXR 2021-09-27 12:45:04 UTC -2.2124 2.2824 250000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund CTXR -2500.0 shares, $-8700.0 2021-06-30 N-PORT

Elevate your investments